Business
MediPharm Labs Corp. Announces Mailing and Filing of Joint Circular for Special Meeting of Shareholders to approve Arrangement with VIVO Cannabis Inc.
MediPharm Labs Corp. Announces Mailing and Filing of Joint Circular for Special Meeting of Shareh...
About this update from Medipharm Labs Corp.
[{"type":"text","content":"\n \n \n \n MediPharm Labs Corp. Announces Mailing and Filing of Joint Circular for Special Meeting of Shareholders to approve Arrangement with VIVO Cannabis Inc.\n \n \n /* Style Definitions */\nspan.prnews_span\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\na.prnews_a\n{\ncolor:blue;\n}\nli.prnews_li\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\np.prnews_p\n{\nfont-size:0.62em;\nfont-family:\"Arial\";\ncolor:black;\nmargin:0in;\n}\n.prngen4{\nPADDING-RIGHT:0.17em; PADDING-LEFT:0.17em; VERTICAL-ALIGN: TOP; TEXT-ALIGN: LEFT; BORDER-TOP:black 1pt; BORDER-RIGHT:black 1pt; BORDER-BOTTOM:black 1pt; BORDER-LEFT:black 1pt\n}\n.prngen2{\nPADDING-RIGHT:0.17em; PADDING-LEFT:0.17em; VERTICAL-ALIGN: TOP; TEXT-ALIGN: RIGHT; BORDER-TOP:black 1pt; BORDER-RIGHT:black 1pt; BORDER-BOTTOM:black 1pt; BORDER-LEFT:black 1pt\n}\n.prnsbbb1{\nBORDER-BOTTOM:black 1pt\n}\n.prnpr4{\nPADDING-RIGHT:0.33em\n}\n.prntal{\nTEXT-ALIGN: LEFT\n}\n.prnvat{\nVERTICAL-ALIGN: TOP\n}\n.prnsblb1{\nBORDER-LEFT:black 1pt\n}\n.prnsbtb1{\nBORDER-TOP:black 1pt\n}\n.prnbcc{\nBORDER-COLLAPSE: COLLAPSE; BORDER-TOP:1pt black; BORDER-RIGHT:1pt black; BORDER-BOTTOM:1pt black; BORDER-LEFT:1pt black\n}\n.prnrbrb1{\nBORDER-RIGHT:black 1pt\n}\n.prnpl2{\nPADDING-LEFT:0.17em\n}\n.prnml4{\nMARGIN-TOP:0em; MARGIN-RIGHT:0em; MARGIN-BOTTOM:0em; MARGIN-LEFT:0.33em !IMPORTANT\n}\n \n \n \n \n \n \n Canada NewsWire\n \n \n \n \n \n \n BARRIE, ON\n \n \n ,\n \n \n Feb. 21, 2023\n \n \n /CNW/ -\n \n MediPharm Labs Corp\n \n . (TSX: LABS) (OTCQX: MEDIF) (FSE: MLZ) (\"MediPharm\", or \"MediPharm Labs\") is pleased to announce the mailing of a joint management information circular of MediPharm and VIVO Cannabis Inc. (\"VIVO\") dated\n \n February 6, 2023\n \n (the \"Circular\") and related documents for the special meeting of MediPharm shareholders to be held virtually at\n \n 1:00 p.m.\n \n (\n \n Toronto\n \n time) on\n \n March 21, 2023\n \n (the \"Meeting\"). The Meeting is being held in connection with the previously announced plan of arrangement under section 192 of the\n \n Canada Business Corporations Act\n \n , whereby MediPharm will acquire all of the issued and outstanding common shares of VIVO (each, a \"VIVO Share\") in an all-equity business combination transaction (the \"Arrangement\").\n \n \n \n \n \n \n \n \n \n Under the terms of the arrangement agree...